SCHEMBL2123199

SCHEMBL2123199

CCCCOC(=O)C(CCCN)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
ATM Q13315 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
TSHR P16473 2/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
CPB2 Q96IY4 1/20 0.39
NOD1 Q9Y239 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GSR P00390 1/20 0.37
CA2 P00918 1/20 0.37
MAPK1 P28482 1/20 0.37
ESR1 P03372 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7996533 0.95 GSR (0.44) ALDH1A1ATMHCAR2MAPTCPB2
SCHEMBL9832203 0.95 NAAA (0.43) ALDH1A1HCAR2TSHRMAPTCPB2
SCHEMBL7449124 0.93 MAPT (0.44) ALDH1A1MAPTCPB2GSR
SCHEMBL5983037 0.91 ALDH1A1 (0.45) ALDH1A1ATMHCAR2TSHRMAPT
SCHEMBL9830216 0.90 MAPT (0.44) HCAR2MAPTCPB2NOD1GSR
SCHEMBL7633731 0.89 ALDH1A1 (0.50) ALDH1A1ATMHCAR2TSHRMAPT
SCHEMBL9184074 0.88 MAPT (0.47) HCAR2MAPTCPB2NOD1
SCHEMBL9362410 0.88 MAPT (0.47) HCAR2MAPTCPB2NOD1
SCHEMBL28070253 0.85 MAPT (0.55) ALDH1A1ATMHCAR2MAPT
SCHEMBL10520107 0.85 ALDH1A1 (0.50) ALDH1A1ATMHCAR2TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443136-A1 NOVEL PEPTIDE DERIVATIVES FOR TREATMENT, PREVENTION OR ALLEVIATION OF A CONDITION ASSOCIATED WITH BONE LOSS OR LOW BONE DENSITY OR TO INHIBIT OSTEOCLAST DIFFERENTIATION AND STIMULATION Neobiotics AB (SE) 2012-04-25 EP disclosed
WO-2010147547-A1 NOVEL PEPTIDE DERIVATIVES FOR TREATMENT, PREVENTION OR ALLEVIATION OF A CONDITION ASSOCIATED WITH BONE LOSS OR LOW BONE DENSITY OR TO INHIBIT OSTEOCLAST DIFFERENTIATION AND STIMULATION NEOBIOTICS AB (SE) 2010-12-23 WO disclosed
EP-1089964-A1 HYDRAZINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2001-04-11 EP disclosed
WO-2000000465-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-01-06 WO disclosed
EP-0617705-A4 NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM. YEDA RES & DEV (IL) 1994-12-28 EP disclosed
EP-0617705-A1 NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM. YEDA RES & DEV (IL) 1994-10-05 EP disclosed
WO-1993009795-A1 NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 1993-05-27 WO disclosed